Charity plans launch of new dementia drug discovery institute
Alzheimer’s Research UK has announced their plans to launch a drug discovery institute which could develop new treatments for those living with dementia. This will be the first institute of its kind in Europe, providing much-needed insight into the disease and investigating potential for the creation of new dementia drugs. The news has been welcomed by experts in dementia research from across the world, and the UK’s top universities have been invited to tender applications to host the new institute, with lead scientists expected to be hired by next year.
Dr Eric Karraan, Director of Research for Alzheimer’s Research UK explained: “The Drug Discovery Institute is the missing link between the UK’s considerable expertise in fundamental science, and industry who can turn discoveries into benefits for people with dementia. We currently have no treatments that act against the disease processes that cause dementia – this institute will change that.”